Ian Li

Ian Li is a Principal at 1315 Capital, a position held since April 2015, with a progression through roles including Vice President, Senior Associate, and Associate. In addition to this, Ian Li serves as a Board Member for CortiCare, 3B Scientific, miraDry, Inc., and Colorescience, and as a Board Observer for NutriSense and previous roles with Bonafide Health, CHC Solutions, Inc., and Aktana. Prior to joining 1315 Capital, Ian Li worked as a Senior Consultant at Capgemini Consulting from May 2012 to April 2015. Ian Li holds a Bachelor of Science in Engineering degree in Biomedical Engineering and Economics from Duke University.